These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Influence of age and smoking on drug kinetics in man: studies using model compounds. Vestal RE; Wood AJ Clin Pharmacokinet; 1980; 5(4):309-19. PubMed ID: 6994978 [TBL] [Abstract][Full Text] [Related]
25. Omeprazole drug interaction studies. Andersson T Clin Pharmacokinet; 1991 Sep; 21(3):195-212. PubMed ID: 1764870 [TBL] [Abstract][Full Text] [Related]
26. [In vivo activity of drug-metabolizing enzymes in various pathological conditions]. Krakovskiĭ ME; Ashirmetov AKh Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279 [TBL] [Abstract][Full Text] [Related]
27. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. Branch RA; Shand DG; Wilkinson GR; Nies AS J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524 [TBL] [Abstract][Full Text] [Related]
28. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs. Perucca E; Hedges A; Makki KA; Richens A Br J Clin Pharmacol; 1980 Nov; 10(5):491-7. PubMed ID: 7437261 [TBL] [Abstract][Full Text] [Related]
29. [Drug metabolism in liver diseases]. Paumgartner G Z Gastroenterol Verh; 1979; 16():42-7. PubMed ID: 95370 [No Abstract] [Full Text] [Related]
30. Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery. Gao L; Ramzan I; Baker AB Anaesth Intensive Care; 2000 Aug; 28(4):375-85. PubMed ID: 10969363 [TBL] [Abstract][Full Text] [Related]
31. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition. Bax ND; Tucker GT; Lennard MS; Woods HF Br J Clin Pharmacol; 1985 May; 19(5):597-603. PubMed ID: 2860914 [TBL] [Abstract][Full Text] [Related]
32. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination]. Soto Alvarez J; Alsar Ortiz MJ Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815 [TBL] [Abstract][Full Text] [Related]
33. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations]. Pellegrin P; Lesne M J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443 [TBL] [Abstract][Full Text] [Related]
34. Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine. Abernethy DR; Greenblatt DJ; Divoll M; Ameer B; Shader RI J Pharmacol Exp Ther; 1983 Mar; 224(3):508-13. PubMed ID: 6827475 [TBL] [Abstract][Full Text] [Related]
35. Drug metabolism in diabetic subjects with fatty livers. Pirttiaho HI; Salmela PI; Sotaniemi EA; Pelkonen RO; Pitkänen U; Luoma PV Br J Clin Pharmacol; 1984 Dec; 18(6):895-9. PubMed ID: 6529530 [TBL] [Abstract][Full Text] [Related]
36. Effect of hypoxia and pregnancy on antipyrine metabolism in isolated perfused rat livers. Brouwer KL; Vore M J Pharmacol Exp Ther; 1985 Sep; 234(3):584-9. PubMed ID: 4032283 [TBL] [Abstract][Full Text] [Related]
37. Impairment of drug elimination in patients with liver disease. Narang AP; Datta DV; Mathur VS Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389 [TBL] [Abstract][Full Text] [Related]
38. [Drug metabolism in patients with liver disease (author's transl)]. Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410 [TBL] [Abstract][Full Text] [Related]
39. Liver function assessment by drug metabolism. Barstow L; Small RE Pharmacotherapy; 1990; 10(4):280-8. PubMed ID: 2388874 [TBL] [Abstract][Full Text] [Related]
40. Effect of inhibitors of prostaglandin synthesis on hepatic drug clearance. Feely J; Wood AJ Br J Clin Pharmacol; 1983 Jan; 15(1):109-11. PubMed ID: 6849732 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]